Skip to content
Screener

Ecolab ECL Global Life Sciences — Operating Income

Other segment segments

Global Institutional & Specialty
$389.9M+5.9%
Global Water
$347.7M+5.5%
Corporate
-$110M-44.7%
Global Pest Elimination
$70.5M+12.8%

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Operating Income
$45M+113%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Operating Income
$2.05M-3.7%
TEC
TECHProtein Sciences — Operating Income
$100M-3.8%
Arrow Electronics logo
ARWGlobal Components — Operating Income
$396.28M+112%
Arrow Electronics logo
ARWGlobal Ecs — Operating Income
$85.38M-12.0%
Henry Schein logo
HSICGlobal Technology — Operating Income
$46M+9.5%

Other financials

Income statement

See full
Revenue$4.4B+9.7%
Gross profit$1.9B+8.0%
Operating income$757.9M+6.7%
Net income$534.9M+2.0%
EPS (diluted)$1.90+3.3%

Balance sheet

See full
Cash & equivalents$5.1B+167%
Total debt$13.3B+8,447%
Total equity$10.1B+7.9%
Total assets$29.9B+26.1%

Cash flow

See full
Operating cash flow$729.5M+3.9%
CapEx$240.1M+10.8%
Free cash flow$489.4M+0.9%

Valuation

See full
Market cap$80.34B+5.4%
Enterprise value$88.55B+19.0%
P/E38×+2.3×
P/S4.8×-0.1×

Profitability

See full
Gross margin44.1%+0.2pp
Operating margin16.9%-1.5pp
Net margin12.6%-1.0pp
FCF margin11.1%+1.1pp

Returns & leverage

See full
Return on equity21.8%-2.4pp
Debt / equity1.3×+1.3×
Current ratio1.8×+0.4×

Where this comes from

Reported directly by Ecolab in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Ecolab’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:05 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053886
(millions)Net SalesCOSSG&ASpecial (gains) and chargesOperating Income (Loss)
Global Water$2,215.5$1,345.9$521.9$-$347.7
Global Institutional & Specialty1,617.4806.5421.0-389.9
Global Pest Elimination350.5197.682.4-70.5
Global Life Sciences221.0107.355.2-58.5
Corporate-4.757.947.4(110.0)
Subtotal at fixed currency rates$4,404.4$2,462.0$1,138.4$47.4$756.6
Effect of foreign currency translation11.01.3
Consolidated reported GAAP$4,415.4$757.9

Item 1. Financial Statements

FAQ

What is Ecolab's global life sciences — operating income?
Ecolab (ECL) reported global life sciences — operating income of $58.5M in Q2 2026.
How has Ecolab's global life sciences — operating income changed year-over-year?
Ecolab's global life sciences — operating income increased by 45.5% year-over-year, from $40.2M to $58.5M.
What is the long-term trend for Ecolab's global life sciences — operating income?
Over 4 years (2021 to 2025), Ecolab's global life sciences — operating income has grown at a 0.5% compound annual growth rate (CAGR), from $152.3M to $155.3M.
What does global life sciences — operating income mean?
Calculated as the segment's revenue minus its cost of goods sold and operating expenses, representing the core profitability of the healthcare and life sciences business. This metric excludes interest, taxes, and corporate-level allocations, providing a clear view of operational performance.

Ask your AI about Ecolab's global life sciences — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude